(Q52129240)

22 April 2018

title

An Appraisal of the Continuing Practice of Prescribing Tranquillizing Drugs for Long-stay Psychiatric Patients (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

12 March 2023

author name string

J. S. Hughes

1

1 reference

PubMed ID

4860437

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4860437

12 March 2023

J. C. Little

2

1 reference

PubMed ID

4860437

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4860437

12 March 2023

language of work or name

English

0 references

publication date

1 August 1967

1 reference

22 April 2018

full work available at URL

number of pages

7

1 reference

based on heuristic

inferred from page(s)

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000084816

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

British Journal of Psychiatry

12 March 2023

published in

1 reference

22 April 2018

volume

113

1 reference

22 April 2018

page(s)

867-873

1 reference

22 April 2018

issue

501

1 reference

22 April 2018

Ten years of chlorpromazine

cites work

1

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

International drug therapy newsletter

12 March 2023

2

i

Ayd

1966

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

A double-blind controlled comparison of the effects of chlorpromazine, barbiturate and a placebo in 142 chronic psychotic in-patients

12 March 2023

3

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

OPHTHALMOLOGIC FINDINGS IN PATIENTS ON LONG-TERM CHLORPROMAZINE THERAPY

12 March 2023

5

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Investigation of a new compound, B.W.203, and of chlorpromazine in the treatment of psychosis

12 March 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Comparison of chlorpromazine and reserpine in maintenance drug therapy

12 March 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Discontinuance of tranquilizers among chronic schizophrenic patients receiving maintenance dosage

12 March 2023

10

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Termination of chlorpromazine with schizophrenic patients

12 March 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

WITHDRAWAL OF LONG-TERM PHENOTHIAZINES FROM CHRONICALLY HOSPITALIZED PSYCHIATRIC PATIENTS

12 March 2023

12

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Intramyocardial lesions in patients dying suddenly and unexpectedly.

12 March 2023

13

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Withdrawal from neuroleptic drugs.

12 March 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

A controlled trial of thiopropazate dihydrochloride (dartalan). chlorpromazine and occupational therapy in chronic schizophrenics

12 March 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Sudden removal of tranquilizing drugs from chronic psychiatric patients

12 March 2023

18

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Results of simultaneous abrupt withdrawal of ataraxics in 500 chronic psychotic patients.

12 March 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Chlorpromazine in the treatment of the chronic disturbed schizophrenic patient

12 March 2023

22

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

An Evaluation of the Effects of Discontinuation of Chlorpromazine

12 March 2023

23

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS

12 March 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

CURRENT THERAPEUTIC RESULTS IN SCHIZOPHRENIA

12 March 2023

25

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

The relative efficacy of vespral and chlorpromazine in the treatment of a group of chronic schizophrenic patients

12 March 2023

26

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Withdrawal of perphenazine in chronic schizophrenia

12 March 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Discontinuation of maintenance dosages of ataractic drugs on a psychiatric continued treatment ward

12 March 2023

29

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

SUDDEN DEATH DURING TREATMENT WITH PHENOTHIAZINE DERIVATIVES.

12 March 2023

31

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

Negative results with chlorpromazine and benactyzine in a group of chronic psychotics, with critical evaluation of similar studies.

12 March 2023

32

1 reference

https://api.crossref.org/works/10.1192/BJP.113.501.867

12 March 2023

Identifiers

1 reference

22 April 2018

PubMed ID

4860437

1 reference

22 April 2018